Sight Sciences Q2 revenue rises 20%, beats estimates

Sight Sciences

05/08/2026 21:49

Overview
US eyecare technology firm's Q2 revenue rose 20% yr/yr, beating analyst expectations
Net loss narrowed 63% yr/yr to $4.4 mln in Q2
Company raised 2026 revenue guidance and cut adjusted operating expense outlook

Outlook
Sight Sciences raises 2026 revenue guidance to $88 mln-$92 mln from $83 mln-$89 mln
Company now sees 2026 Interventional Glaucoma revenue at $79 mln-$81 mln, up 4%-7%
Company reduces 2026 adjusted operating expense guidance to $92 mln-$94 mln from $93 mln-$96 mln

Result Drivers
DRY EYE SEGMENT GROWTH - Interventional Dry Eye revenue rose sharply, driven by increased volumes and higher average selling prices
GLAUCOMA SEGMENT VOLUMES - Interventional Glaucoma revenue increased, primarily due to higher volumes
OPERATING EXPENSE REDUCTION - Total operating expenses fell 11% yr/yr, mainly due to lower personnel-related expenses and stock-based compensation

Company press release: ID:nGNX7NMcL5

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$23.40 mln
$21.68 mln (7 Analysts)
Q2 Net Loss
 
$4.40 mln
 
Q2 Gross Margin
 
91.00%
 
Q2 Gross Profit
 
$21.40 mln
 
Q2 Operating Expenses
 
$25.30 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Sight Sciences, Inc. is $8.00, about 41.8% above its August 4 closing price of $5.64

Reuters Recommended Reads
Aug 5 - Canada's Kits Eyecare Q2 revenue slightly beats on glasses segment growth
Aug 3 - Ocular Therapeutix Q2 product revenue flat, net loss widens on higher spending
Aug 5 - EyePoint Pharmaceuticals Q2 revenue drops on lower license income

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)